Results     27-May-13
Announcements
Marksans Pharma reports net profit of Rs 37.01 crore in the March 2013 quarter
Sales rise 45.19% to Rs 58.67 crore
Net profit of Marksans Pharma reported to Rs 37.01 crore in the quarter ended March 2013 as against net loss of Rs 118.04 crore during the previous quarter ended March 2012. Sales rose 45.19% to Rs 58.67 crore in the quarter ended March 2013 as against Rs 40.41 crore during the previous quarter ended March 2012.

For the Audited full year,net profit reported to Rs 39.58 crore in the year ended March 2013 as against net loss of Rs 181.07 crore during the previous year ended March 2012. Sales rose 24.39% to Rs 192.30 crore in the year ended March 2013 as against Rs 154.59 crore during the previous year ended March 2012.

ParticularsQuarter EndedYear Ended
 Mar. 2013Mar. 2012% Var.Mar. 2013Mar. 2012% Var.
Sales58.6740.41 45 192.30154.59 24
OPM %54.87-288.52 119 25.19-99.00 125
PBDT29.21-120.00 LP 38.30-164.93 LP
PBT27.03-119.88 LP 29.60-182.91 LP
NP37.01-118.04 LP 39.58-181.07 LP

Previous News
  Marksans Pharma consolidated net profit rises 36.36% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   15:15 )
  Marksans Pharma consolidated net profit rises 31.37% in the December 2022 quarter
 ( Results - Announcements 13-Feb-23   14:08 )
  Marksans announces receipt of marketing authorization for Levonorgestrel 1.5 mg Tablets
 ( Corporate News - 02-Aug-24   16:12 )
  Marksans Pharma arm receives UK MHRA approval for four products
 ( Corporate News - 02-Jul-24   13:41 )
  Marksans Pharma receives USFDA approval for Esomeprazole Magnesium Delayed-Release Capsules
 ( Corporate News - 03-Oct-23   15:15 )
  Marksans Pharma receives affirmation in credit ratings from CARE
 ( Corporate News - 12-Oct-23   14:30 )
  Marksans Pharma consolidated net profit rises 26.80% in the June 2021 quarter
 ( Results - Announcements 11-Aug-21   17:29 )
  Marksans Pharma to table results
 ( Corporate News - 31-Jul-24   14:13 )
  Marksans Pharma consolidated net profit declines 62.70% in the March 2022 quarter
 ( Results - Announcements 31-May-22   14:42 )
  Marksans Pharma to convene board meeting
 ( Corporate News - 02-Aug-22   10:50 )
  Marksans Pharma receives UK MHRA approval for Fluoxetine 20mg/5ml Oral Solution
 ( Corporate News - 23-Jan-23   13:41 )
Other Stories
  Shri Bholanath Carpets reports standalone net profit of Rs 0.02 crore in the June 2024 quarter
  30-Sep-24   07:34
  Gala Precision Engineering consolidated net profit rises 38.55% in the June 2024 quarter
  30-Sep-24   07:34
  Kross standalone net profit declines 4.25% in the June 2024 quarter
  28-Sep-24   07:36
  Jamna Auto Industries consolidated net profit rises 1.73% in the June 2024 quarter
  28-Sep-24   07:35
  Baazar Style Retail reports standalone net loss of Rs 0.39 crore in the June 2024 quarter
  26-Sep-24   07:35
  Mysore Paper Mills reports standalone net loss of Rs 22.19 crore in the June 2024 quarter
  26-Sep-24   07:35
  Educomp Solutions reports standalone net loss of Rs 1.81 crore in the June 2024 quarter
  25-Sep-24   07:30
  Ecos (India) Mobility & Hospitality consolidated net profit declines 3.08% in the June 2024 quarter
  25-Sep-24   07:30
  Orissa Minerals Development Company reports standalone net loss of Rs 2.08 crore in the June 2024 quarter
  24-Sep-24   07:43
  Apis India consolidated net profit declines 40.92% in the June 2024 quarter
  21-Sep-24   07:30
Back Top